# A Study Evaluating Treatment Regimens Containing Vebicorvir (ABI-H0731) in Participants With Chronic Hepatitis B Infection

> **NCT04820686** · PHASE2 · TERMINATED · sponsor: **Assembly Biosciences** · enrollment: 65 (actual)

## Conditions studied

- Chronic Hepatitis B

## Interventions

- **DRUG:** VBR
- **DRUG:** AB-729
- **DRUG:** SOC NrtI

## Key facts

- **NCT ID:** NCT04820686
- **Lead sponsor:** Assembly Biosciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-05-07
- **Primary completion:** 2023-03-30
- **Final completion:** 2023-03-30
- **Target enrollment:** 65 (ACTUAL)
- **Why stopped:** Sponsor decision
- **Last updated:** 2023-11-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04820686

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04820686, "A Study Evaluating Treatment Regimens Containing Vebicorvir (ABI-H0731) in Participants With Chronic Hepatitis B Infection". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04820686. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*